Official Title
Risk Stratification of Patients With Suspected COVID-19 Presenting to the ED (EUROCOV Study)
Brief Summary

This project is an unfunded collaboration of approximately 30 emergency departments across Europe led by the EUSEM research network. It involves collection of data in relation to determining the epidemiology and outcome of adult patients who present to emergency departments with a suspected Covid infection.

Detailed Description

Over the past 6 months, the world has faced a novel infection disease outbreak, due to a
novel coronavirus, the severe acute respiratory syndrome coronavirus (SARS-CoV2), with a
massive impact on healthcare resource.

In Europe, numbers of confirmed cases continue to rise. Europe is currently one of the
regions with the highest number of Covid-19 cases and deaths due to this emergent diseases.

Most COVID-19 infected patients present with mild to moderate acute respiratory symptoms,
including cough, fever, dyspnea and pneumonia. About 20% will present with severe or critical
manifestations of the disease, including pneumonia, respiratory failure and acute respiratory
distress syndrome (ARDS).

Anticipating the needs for hospitalization in ward and/or intensive care is crucial.

Emergency departments are at the front line for triaging patients with suspected Covid-19 and
referring them to the appropriate level of care.

In Europe, the number of ED patients with suspected Covid-19 is variable; rate of
hospitalization from ED reaches 40% for this population.

Risk stratification and management decisions of patients presenting to the ED with suspected
COVID-19 is a challenge for emergency physicians.

Unknown status
COVID19
Eligibility Criteria

Inclusion Criteria:

- Adult patients (>= 18 years old) attending the ED with a clinical suspicion of
COVID-19 based on the presence of the following criteria

- Fever >= 38 °C

- respiratory symptoms (dyspnea, cough, expectorations)

- any other symptoms suggestive of COVID-19 including digestive signs (diarrhea,
anosmia…)

Exclusion Criteria:

- None

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 130 Years
Countries
Croatia
Finland
France
Greece
Italy
Locations

EUSEM RN Country lead
Zagreb, Croatia

EUSEM RN Country lead
Hämeenlinna, Finland

EUSEM RN Country lead
Tours, France

EUSEM RN Country lead
Athens, Greece

EUSEM RN Country lead
Forlì, Italy

Said LARIBI, MD, PhD, Principal Investigator
EUSEM Research network chair

European Society for Emergency Medicine (EUSEM) Research Network
NCT Number
Keywords
COVID19
Emergencies
Epidemiology
Prognosis
MeSH Terms
COVID-19